JP2024533371A5 - - Google Patents
Info
- Publication number
- JP2024533371A5 JP2024533371A5 JP2024515376A JP2024515376A JP2024533371A5 JP 2024533371 A5 JP2024533371 A5 JP 2024533371A5 JP 2024515376 A JP2024515376 A JP 2024515376A JP 2024515376 A JP2024515376 A JP 2024515376A JP 2024533371 A5 JP2024533371 A5 JP 2024533371A5
- Authority
- JP
- Japan
- Prior art keywords
- formulas
- nucleotides
- nucleotide
- nucleotide sequence
- sina
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163241935P | 2021-09-08 | 2021-09-08 | |
| US63/241,935 | 2021-09-08 | ||
| PCT/US2022/042808 WO2023039005A2 (en) | 2021-09-08 | 2022-09-07 | Modified short interfering nucleic acid (sina) molecules and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533371A JP2024533371A (ja) | 2024-09-12 |
| JP2024533371A5 true JP2024533371A5 (cg-RX-API-DMAC7.html) | 2025-09-16 |
Family
ID=83506451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515376A Pending JP2024533371A (ja) | 2021-09-08 | 2022-09-07 | 修飾された短い干渉核酸(siNA)分子及びそれらの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12454691B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4399217A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024533371A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240099159A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118201942A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022344131A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3231695A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202320809A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023039005A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118271378A (zh) * | 2022-12-29 | 2024-07-02 | 中国科学院深圳先进技术研究院 | 一种糖环修饰的核苷亚磷酰胺单体及其制备方法和应用 |
| CN119836430A (zh) * | 2023-05-12 | 2025-04-15 | 北京炫景瑞医药科技有限公司 | 修饰的核苷类似物及其用途与含核苷酸类似物的双链寡核苷酸及其用途 |
| CN121772930A (zh) * | 2023-07-31 | 2026-03-31 | 基愈治疗股份有限公司 | N-乙酰基-半乳糖胺(galnac)和寡核苷酸的缀合物以及其用途 |
| CN117534717A (zh) * | 2024-01-09 | 2024-02-09 | 凯莱英生命科学技术(天津)有限公司 | 5′-(e)-乙烯基磷酸酯的合成方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6218108B1 (en) * | 1997-05-16 | 2001-04-17 | Research Corporation Technologies, Inc. | Nucleoside analogs with polycyclic aromatic groups attached, methods of synthesis and uses therefor |
| CA2522349A1 (en) * | 2003-04-17 | 2004-11-04 | Alnylam Pharmaceuticals, Inc. | Protected monomers |
| CA2701845A1 (en) * | 2007-10-03 | 2009-04-09 | Quark Pharmaceuticals, Inc. | Novel sirna structures |
| WO2011094953A1 (en) | 2010-02-08 | 2011-08-11 | F. Hoffmann-La Roche Ag | Compounds for the treatment and prevention of influenza |
| WO2011139702A2 (en) | 2010-04-28 | 2011-11-10 | Isis Pharmaceuticals, Inc. | Modified nucleosides and oligomeric compounds prepared therefrom |
| WO2011139699A2 (en) * | 2010-04-28 | 2011-11-10 | Isis Pharmaceuticals, Inc. | 5' modified nucleosides and oligomeric compounds prepared therefrom |
| ES2952714T3 (es) | 2013-06-26 | 2023-11-03 | Janssen Pharmaceuticals Inc | Nucleósidos sustituidos, nucleótidos y análogos de los mismos |
| WO2018013999A1 (en) | 2016-07-15 | 2018-01-18 | Am Chemicals Llc | Non-nucleosidic solid supports and phosphoramidite building blocks for oligonucleotide synthesis |
| JOP20170056B1 (ar) | 2016-09-02 | 2021-08-17 | Arrowhead Pharmaceuticals Inc | مركبات ترابطية مستهدفة |
| WO2018045317A1 (en) | 2016-09-02 | 2018-03-08 | Dicerna Pharmaceuticals, Inc. | 4'-phosphate analogs and oligonucleotides comprising the same |
| EP3735252A4 (en) * | 2018-01-04 | 2021-10-06 | Avidity Biosciences, Inc. | HETERODUPLEX NUCLEIC ACID MOLECULES AND USES THEREOF |
| WO2019217397A2 (en) | 2018-05-07 | 2019-11-14 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for improving strand biased |
| US20200147124A1 (en) | 2018-11-08 | 2020-05-14 | Aligos Therapeutics, Inc. | S-antigen transport inhibiting oligonucleotide polymers and methods |
| KR20210126636A (ko) | 2019-02-14 | 2021-10-20 | 알리고스 테라퓨틱스 인코포레이티드 | 이환식 설폰아마이드 |
| IL286902B2 (en) | 2019-04-03 | 2025-03-01 | Aligos Therapeutics Inc | Pyrrole compounds |
| EP3956331A4 (en) | 2019-04-17 | 2023-01-11 | Aligos Therapeutics, Inc. | BICYCLIC AND TRICYCLIC COMPOUNDS |
| WO2021119325A1 (en) * | 2019-12-12 | 2021-06-17 | Aligos Therapeutics, Inc. | S-antigen transport inhibiting oligonucleotide polymers and methods |
| US20240352464A1 (en) * | 2023-03-07 | 2024-10-24 | Aligos Therapeutics, Inc. | Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof |
-
2022
- 2022-09-07 KR KR1020247011543A patent/KR20240099159A/ko active Pending
- 2022-09-07 EP EP22782624.5A patent/EP4399217A2/en active Pending
- 2022-09-07 CA CA3231695A patent/CA3231695A1/en active Pending
- 2022-09-07 US US17/939,896 patent/US12454691B2/en active Active
- 2022-09-07 JP JP2024515376A patent/JP2024533371A/ja active Pending
- 2022-09-07 AU AU2022344131A patent/AU2022344131A1/en active Pending
- 2022-09-07 CN CN202280074016.XA patent/CN118201942A/zh active Pending
- 2022-09-07 TW TW111133970A patent/TW202320809A/zh unknown
- 2022-09-07 WO PCT/US2022/042808 patent/WO2023039005A2/en not_active Ceased
-
2025
- 2025-09-09 US US19/323,023 patent/US20260002157A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7792371B2 (ja) | GalNAc誘導体 | |
| US10889817B2 (en) | Oligonucleotide therapy for Leber Congenital Amaurosis | |
| JP6752151B2 (ja) | 遺伝子サイレンシングにおいて低下したoff−target効果を有するunaオリゴマー | |
| JP2023123469A (ja) | B型肝炎ウイルス感染のためのRNAi薬 | |
| TW202113079A (zh) | 經修飾之間隙子寡核苷酸及其使用方法 | |
| JP2018520685A (ja) | B型肝炎ウイルスに対する組成物および薬剤ならびにその使用 | |
| CN113507920A (zh) | 用于乙型肝炎病毒感染的RNAi剂 | |
| JP2019515663A5 (cg-RX-API-DMAC7.html) | ||
| JP2023509870A (ja) | Hbvの処置のためのhbvを標的とする治療用オリゴヌクレオチドとtlr7アゴニストとの医薬組合せ | |
| WO2017106244A1 (en) | Compositions and methods for regulatable antibody expression | |
| IL277970B2 (en) | Oligomeric compounds comprising modified oligonucleotides and conjugated groups for use in the treatment of end-stage renal disease, chronic kidney disease and coronary artery disease | |
| JP2021534154A5 (cg-RX-API-DMAC7.html) | ||
| CN119654412A (zh) | 激活补体因子h表达的寡核苷酸调节剂 | |
| JP2025072578A (ja) | B型肝炎ウイルス感染症を処置するためのsept9阻害剤の使用 | |
| CA3178591A1 (en) | Immunosuppressive agents and viral delivery re-dosing methods for gene therapy | |
| JP2023530379A5 (cg-RX-API-DMAC7.html) | ||
| JP2023509872A (ja) | Hbvを標的とする抗ウイルス剤及び/又はhbvの処置のための免疫調節剤の医薬組合せ | |
| US20230383296A1 (en) | Modified gapmer oligomers and methods of use thereof | |
| US11898145B2 (en) | Enhanced oligonucleotides for inhibiting RTEL1 expression | |
| JP2022510346A5 (cg-RX-API-DMAC7.html) | ||
| CN119709734A (zh) | 用于干扰乙型肝炎病毒的siRNA及其用途 | |
| CN121793974A (zh) | 用于治疗肌少症的组合物和方法 | |
| HK40036011A (en) | Galnac derivatives | |
| HK40062579A (en) | Rnai agents for hepatitis b virus infection | |
| WO2024235124A1 (zh) | 修饰的核苷类似物及其用途与含核苷酸类似物的双链寡核苷酸及其用途 |